Caroline Bullerjahn

Caroline Bullerjahn, a partner in Goodwin’s Securities Litigation practice and a leader of the firm’s Life Sciences Disputes group, focuses her securities litigation practice on class action and derivative litigation defense, SEC, and other government, regulatory and internal investigations, fiduciary duty claims, corporate governance matters, and shareholder disputes, M&A-related litigation and post-closing disputes, and SPAC litigation. She is a member of the firm’s Partnership Committee and the co-chair of the firm’s global Dobbs Task Force.

JD, Northwestern University 2003; BA, University of Pennsylvania 1998 (magna cum laude)